Gastrointestinal stromal tumours: outcomes of surgical management and analysis of prognostic variables

Canadian Journal of Surgery

Volumn 52, Issue 1, 2009, Pages 31-38

  Unalp, Haluk R ^a   Derici, Hayrullah ^a   Kamer, Erdinc ^a   Bozdag, Ali D ^a   Tarcan, Ercument ^a   Onal, Mehmet A ^a  

^a ATATURK TRAINING AND RESEARCH HOSPITAL   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 62249116435     PISSN: 0008428X     EISSN: 14882310     Source Type: Journal    
DOI: None     Document Type: Review

References (45)

1. Kindblom LG, Remotti HE, Aldenborg F, et al. Gastrointestinal pacemaker cell tumor (GIPACT): gastrointestinal stromal tumors show phenotypic characteristics of the interstitial cells of Cajal. Am J Pathol 1998;152:1259-69.
2. Rossi CR, Mocellin S, Mencarelli R, et al. Gastrointestinal stromal tumors: from a surgical to a molecular approach. Int J Cancer 2003;107: 171-6.
3. Miettinen M, Majidi M, Lasota J. Pathology and diagnostic criteria of gastrointestinal stromal tumors (GISTs): a review. Eur J Cancer 2002;38 Suppl 5:S39-51.
4. Sturgeon C, Chejfec G, Espat N. Gastrointestinal stromal tumors: a spectrum of diseases. Surg Oncol 2003;12:21-6.
5. Besana-Ciani I, Boni L, Dionigi G, et al. Outcome and long term results of surgical resection for gastrointestinal stromal tumors (GIST). Scand J Surg 2003 ;92:195-9.
6. Mazur MT, Clark HB. Gastric stromal tumors. Reappraisal of histogenesis. Am J Surg Pathol 1983;7:507-19.
7. Trupiano JK, Stewart R, Misick C, et al. Gastric stromal tumors, a clinicopathological study of 77 cases with correlation of features with nonaggressive and aggressive clinical behaviour. Am J Surg Pathol 2002; 26:705-14.
8. Joensuu H, Fletcher C, Dimitrijevic S, et al. Management of malignant gastrointestinal stromal tumours. Lancet Oncol 2002;3:655-64.
9. Lev D, Kariv Y, Issakov J, et al. Gastrointestinal stromal sarcomas. Br J Surg 1999;86:545-9.
10. Bauer S, Corless CL, Heinrich MC, et al. Response to imatinib mesylate of a gastrointestinal stromal tumor with very low expression of KIT. Cancer Chemother Pharmacol 2003;51:261-5.
11. El-Zohairy M, Khalil el-SA, Fakhr I, et al. Gastrointestinal stromal tumor (GIST)'s surgical treatment, NCI experience. J Egypt Natl Cane Inst 2005;17:56-66.
12. Gold JS, Dematteo RP. Combined surgical and molecular therapy: the gastrointestinal stromal tumor model. Ann Surg 2006;244:176-84.
13. Miller TA. Leimyosarcoma: Not all gastric malignancies have a dismal prognosis. Gastroenterology 1993;104:940-1.
14. Yamashita F, Sasatomi E, Kiyama M, et al. Radiographic observation of a case of gastrointestinal stromal tumor in stomach. Kurume Med J 2001;48:233-6.
15. Ghanem N, Altehoefer C, Furtwangler A, et al. Computed tomography in gastrointestinal stromal tumors. Eur Radiol 2003;13:1669-78.
16. Tateishi U, Hasegawa T, Satake M, et al. Gastrointestinal stromal tumor. Correlation of computed tomography findings with tumor grade and mortality. J Comput Assist Tomogr 2003;27:792-8.
17. Shojaku H, Futatsuya R, Seto H, et al. Malignant gastrointestinal stromal tumor of the small intestine: radiologic-pathologic correlation. Radiat Med 1997;15:189-92.
18. Stroobants S, Goeminne J, Seegers M, et al. 18FDG-Positron emission tomography for the early prediction of response in advanced soft tissue sarcoma treated with imatinib mesylate (Glivec). Eur J Cancer 2003;39:2012-20.
19. Chak A, Canto MI, Rosch T, et al. Endosonographic differentiation of benign and malignant stromal cell tumors. Gastrointest Endosc 1997;45:468-73.
20. Belloni M, De Fiori E, Mazzarol G, et al. Endoscopic ultrasound and computed tomography in gastric stromal tumours. Radiol Med (Torino) 2002;103:65-73.
21. Ng EH, Pollock RE, Munsell MF, et al. Prognostic factors influencing survival in gastrointestinal leiomyosarcomas. Implications for surgical management and staging. Ann Surg 1992;215:68-77.
22. Conlon KC, Casper ES, Brennan MF. Primary gastrointestinal sarcomas: analysis of prognostic variables. Ann Surg Oncol 1995;2:26-31.
23. Burkill GJ, Badran M, Al-Muderis O, et al. Malignant gastrointestinal stromal tumor: distribution, imaging features, and pattern of metastatic spread. Radiology 2003;226:527-32.
24. Sawaki A, Yamao K. Imatinib mesylate acts in metastatic or unresectable gastrointestinal stromal tumor by targeting KIT receptors - a review. Cancer Chemother Pharmacol 2004;54 Suppl 1 :S44-9.
25. Miettinen M, Sarlomo-Rikala M, Lasota J. Gastrointestinal stromal tumors: recent advances in understanding of their biology. Hum Pathol 1999;30:1213-20.
26. DeMatteo RP, Lewis JJ, Leung D, et al. Two hundred gastrointestinal stromal tumors: recurrence patterns and prognostic factors for survival. AnnSurg 2000;231:51-8.
27. Miettinen M, El-Rifai W, Sobin LH, et al. Evaluation of malignancy and prognosis of gastrointestinal stromal tumors: a review. Hum Pathol 2002;33:478-83.
28. Fujimoto Y, Nakanishi Y, Yoshimura K, et al. Clinico-pathologic study of primary malignant gastrointestinal stromal tumor of the stomach, with special reference to prognostic factors: analysis of results in 140 surgically resected patients. Gastric Cancer 2003;6:39-48.
29. McGrath PC, Neifeld JP, Lawrence W Jr, et al. Gastrointestinal sarcomas. Analysis of prognostic factors. Ann Surg 1987;206:706-10.
30. Wu PC, Langerman A, Ryan CW, et al. Surgical treatment of gastrointestinal stromal tumors in the imatinib (STI-571) era. Surgery 2003;134:656-65.
31. Langer C, Gunawan B, Schuler P, et al. Prognostic factors influencing surgical management and outcome of gastrointestinal stromal tumours. Br J Surg 2003;90:332-9.
32. Crosby JA, Catton CN, Davis A, et al. Malignant gastrointestinal stromal tumors of the small intestine: a review of 50 cases from a prospective database. Ann Surg Oncol 2001;8:50-9.
33. Pidhorecky I, Cheney RT, Kraybill WG, et al. Gastrointestinal stromal tumors: current diagnosis, biologic behavior, and management. Ann Surg Oncol 2000;7:705-12.
34. Pierie JP, Choudry U, Muzikansky A, et al. The effect of surgery and grade on outcome of gastrointestinal stromal tumors. Arch Surg 2001; 136:383-9.
35. Fletcher C, Berman J, Corless C, et al. Diagnosis of gastrointestinal stromal tumors: a consensus approach. HumPathol 2002;33:459-65.
36. Lillemoe KD, Efron DT. Gastrointestinal stromal tumors. In Cameron JL, editor. Current surgical therapy. Philadelphia: Mosby; 2001. p. 112-7.
37. Bilimoria MM, Holtz DJ, Mirza NQ, et al. Tumor volume as a prognostic factor for sarcomatosis. Cancer 2002;94:2441-6.
38. Shawver LK, Slamon D, Ullrich A. Smart drugs: tyrosine kinase inhibitors in cancer therapy. Cancer Cell 2002; 1:117-2 3.
39. Roberts PJ, Eisenberg B. Clinical presentation of gastrointestinal stromal tumors and treatment of operable disease. Eur J Cancer 2002;38 Suppl:S37-8.
40. Demetri GD, von Mehren M, Blanke CD, et al. Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors. N Engl J Med 2002;347:472-80.
41. Shiu MH, Farr GH, Papachristou DN, et al. Myosarcomas of the stomach: natural history, prognostic factors and management. Cancer 1982;49:177-87.
42. Lewis JJ, Leung D, Woodruff JM, et al. Retroperitoneal soft-tissue sarcoma: analysis of 500 patients treated and followed at a single institution. Ann Surg 1998;228:355-65.
43. Duffaud F, Blay JY. Gastrointestinal stromal tumors: biology and treatment. Oncology 2003;65:187-97.
44. Bucher P, Villiger P, Egger JF, et al. Management of gastrointestinal stromal tumours: from diagnosis to treatment. Swiss Med Wkly 2004; 134:145-53.
45. Kubota T. Gastrointestinal stromal tumor (GIST) and imatinib. Int J Clin Oncol 2006;11:184-9.